Skip to main content
main content, press tab to continue
Press Release

Global health care benefit cost increases expected to jump by more than 8% in 2021, Willis Towers Watson survey finds

October 6, 2020

UK private healthcare cost increases continue to rise in 2020 and 2021, above the European average.
Health and Benefits

LONDON, 6 October 2020 — Employer-sponsored health care benefit costs are expected to increase by more than 8% around the globe next year following a year in which the COVID-19 pandemic had a significant impact on health care use and overall costs, according to a survey of medical insurers by Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company.

The 2021 Global Medical Trends Survey the largest of its kind, found medical insurers globally project health care benefit costs will take a sudden drop in 2020 before rebounding to 8.2% in 2021, up from 5.9% this year and 7.2% in. Average increases in the five regions next year will range from 5.8% in Europe to 13.6% in Latin America. Health care benefit cost increases in the U.S. are expected to remain stable at 7.3% next year, according to other Willis Towers Watson research.

In the UK, the cost of private medical insurance continues to edge upward despite the impact of COVID-19, from 5.7% in 2019, to 6.3% in 2020 and an anticipated increase of 6.5% in 2021. Contributing factors include a maturing insured demographic and aging workforce. The report also notes the impact of high-cost treatments, such as new generation cancer drug therapies and wider availability of more complex medical treatments.

The study also found over two-thirds (68%) of respondents expect medical costs will continue to accelerate over the next three years. Nine in ten (89%) Middle East and Africa insurers expect higher medical trends over the next three years followed by insurers in Europe (77%). Only four in ten (39%) Asia Pacific insurers expect higher medical trends.

Global medical trends: Health care benefit cost growth, 2019 – 2021

*UK results also included in average for Europe
+Due to the hyperinflationary nature of the Venezuelan economy, Venezuela has been excluded from Latin America regional and global totals. Including Venezuela, the 2020 global average trends would be 7.2%, and Latin American average trends would be 14.8%.
2019 2020 2021
Global+ 7.2% 5.9% 8.2%
North America 5.6% 2.8% 8.5%
Latin America+ 11.0% 9.2% 13.6%
Asia Pacific 7.5% 6.2% 8.5%
Europe 5.6% 4.2% 5.8%
*United Kingdom 5.7% 6.3% 6.5%
Middle East/Africa 8.7% 8.7% 10.0%

“The pandemic undoubtedly had a major impact on medical trend this year as it sparked a sharp decline in non-urgent surgeries and elective care,” said Kevin Newman, managing director of Willis Towers Watson’s UK Health & Benefits business. “While most countries experienced a decrease in trend this year, that is expected to be short-lived. In fact, we expect to see significant volatility in 2021 results, which are dependent on the impact of COVID-19 and whether or not a vaccine becomes available early in the year, who pays for it and the extent of its availability. In addition, there is uncertainty about how COVID-19 testing and treatment costs for 2021 will continue to be split between government, insurers and employers.”

According to the survey, cancer (79%), cardiovascular diseases (56%), and conditions affecting musculoskeletal and connective tissue (41%) are the top three conditions currently affecting medical costs. But about four in ten predict mental health conditions will be among the three most common conditions affecting costs within the next 18 months (41%), and among the three most expensive in the next 18 months (39%).

When asked for the most significant cost-driving factors outside the control of employers and vendors, just over half of respondents (52%) cited the high cost of medical technology, followed by providers’ profit motives (36%) and epidemics and global pandemics (34%).

Further uncertainty around medical trend lies ahead as we start to see the true impact of delayed treatment in 2020.”

Kevin Newman,
managing director of Willis Towers Watson’s UK Health & Benefits business

“Further uncertainty around medical trend lies ahead as we start to see the true impact of delayed treatment in 2020 and the long-term effects on those who contracted COVID-19. Nevertheless, there is a silver lining as COVID-19 has greatly accelerated the adoption and use of telehealth, which could help to offset those potential higher costs and provide a more efficient way for insureds to access and use healthcare in the future. However, it may also boost utilisation due to ease of access!” said Newman.

About the survey

The Willis Towers Watson 2021 Global Medical Trends Survey was conducted between July and September 2020 and reflects responses from 287 leading medical insurers operating in 76 countries.

About Willis Towers Watson

Willis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 45,000 employees serving more than 140 countries and markets. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential.

Related content tags, list of links Press Release Health and Benefits
Contact us